Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.25.1
Consolidated Statements of Operations - USD ($)
shares in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 12,537,000 $ 15,169,000
General and administrative 5,341,000 5,990,000
Legal settlement (2,600,000)
Total operating expenses 17,878,000 18,559,000
Loss from operations (17,878,000) (18,559,000)
Other income (expense):    
Interest income, net 537,000 640,000
Foreign exchange loss (163,000) (65,000)
Total other income, net 374,000 575,000
Net loss $ (17,504,000) $ (17,984,000)
Net loss per common share, basic $ (1.72) $ (1.87)
Net loss per common share, diluted $ (1.72) $ (1.87)
Weighted average number of common shares, basic 10,174 9,651
Weighted average number of common shares, diluted 10,174 9,651